BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Staging
9 results:

  • 1. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
    Sang Y; Min R; Huang T; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hemithyroidectomy and ipsilateral central neck dissection for T1 low-risk papillary thyroid cancer: single-institution retrospective observational study.
    Giordano D; Botti C; Piana S; Castellucci A; Frasoldati A; Zini M; Fornaciari M; Crocetta FM; Ghidini A
    Eur J Endocrinol; 2022 Mar; 186(5):535-542. PubMed ID: 35230264
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
    Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
    Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Markers Involved in Tumorigenesis of thyroid Carcinoma: Focus on Aggressive Histotypes.
    Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
    Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
    Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C
    Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
    Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
    Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predictive factors related to the recurrence at US-guided fine needle aspiration in postoperative patients with differentiated thyroid cancer.
    Hahn SY; Shin JH; Han BK; Ko EY; Kang SS; Chung JH; Kim JH; Oh YL; Son YI
    Clin Endocrinol (Oxf); 2011 Feb; 74(2):270-5. PubMed ID: 21044120
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Revisiting serum thyroglobulin in the follow-up of patients with differentiated thyroid carcinoma].
    Rosário PW; Cardoso LD; Fagundes TA; Barroso AL; Padrão EL; Rezende LL; Purisch S
    Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):480-6. PubMed ID: 15761510
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.
    Papini E; Guglielmi R; Bianchini A; Crescenzi A; Taccogna S; Nardi F; Panunzi C; Rinaldi R; Toscano V; Pacella CM
    J Clin Endocrinol Metab; 2002 May; 87(5):1941-6. PubMed ID: 11994321
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.